Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Reilly

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Cardiology|January 1, 1993
Antiplatelet efficacy and specificity of DMP728, a novel platelet GPIIb/IIIa receptor antagonistS A Mousa, J M Bozarth, M S Forsythe, et al.
The American Journal of Physiology|March 1, 1995
Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulationY T Wachtfogel, C E Hack, J H Nuijens, et al.
Cancer Research|April 15, 1990
Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell lineR S Morrison, J L Gross, W F Herblin, et al.
Thrombosis and Haemostasis|November 3, 1998
Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activationY T Wachtfogel, C Kettner, C E Hack, et al.
Biopharmaceutics & Drug Disposition|March 4, 2000
Disposition and exposure of the fibrinogen receptor antagonist XV459 on alphaIIBbeta3 binding sites in the guinea pigJ S Barrett, J Yu, R Kapil, et al.
Coronary Artery Disease|October 1, 1996
Novel nonpeptide antiplatelet glycoprotein IIb/IIIa receptor antagonist, DMP754: receptor binding affinity and specificityS A Mousa, M Forsythe, W Lorelli, et al.
Journal of Cardiovascular Pharmacology|August 13, 1998
Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802S A Mousa, R E Olson, J M Bozarth, et al.
Journal of Medicinal Chemistry|April 10, 1999
Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of actionR E Olson, T M Sielecki, J Wityak, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Cardiology|January 1, 1993
Antiplatelet efficacy and specificity of DMP728, a novel platelet GPIIb/IIIa receptor antagonistS A Mousa, J M Bozarth, M S Forsythe, et al.
The American Journal of Physiology|March 1, 1995
Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulationY T Wachtfogel, C E Hack, J H Nuijens, et al.
Cancer Research|April 15, 1990
Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell lineR S Morrison, J L Gross, W F Herblin, et al.
Thrombosis and Haemostasis|November 3, 1998
Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activationY T Wachtfogel, C Kettner, C E Hack, et al.
Biopharmaceutics & Drug Disposition|March 4, 2000
Disposition and exposure of the fibrinogen receptor antagonist XV459 on alphaIIBbeta3 binding sites in the guinea pigJ S Barrett, J Yu, R Kapil, et al.
Coronary Artery Disease|October 1, 1996
Novel nonpeptide antiplatelet glycoprotein IIb/IIIa receptor antagonist, DMP754: receptor binding affinity and specificityS A Mousa, M Forsythe, W Lorelli, et al.
Journal of Cardiovascular Pharmacology|August 13, 1998
Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802S A Mousa, R E Olson, J M Bozarth, et al.
Journal of Medicinal Chemistry|April 10, 1999
Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of actionR E Olson, T M Sielecki, J Wityak, et al.
Pageof 8